IPP Bureau
AstraZeneca partners with Honeywell to develop next-gen respiratory inhalers
By IPP Bureau - February 22, 2022
New inhalers would have near-zero Global Warming Potential propellant
Mental healthcare app heyy raises pre-seed funding
By IPP Bureau - February 22, 2022
US $ 555,000 invested by Wavemaker Partners in pre-seed round
Velocity Clinical Research invests in Indian tech, acquires TrierHealth
By IPP Bureau - February 22, 2022
The investment in Indian clinical technology expertise in Hyderabad comes amid the clinical trials sector's move towards decentralised trials
UK MHRA approves Marksans All in One oral solution
By IPP Bureau - February 22, 2022
Therapeutic use of the product is for short term symptomatic relief of colds, chills and influenza including chesty coughs
Asahi Kasei to build new production unit for membrane virus filters in Japan
By IPP Bureau - February 22, 2022
The COVID-19 pandemic has triggered the rapid growth of the biotherapeutics market
Solvay invests in Zurich-based 3D printing startup
By IPP Bureau - February 22, 2022
9T Labs provides a cost-competitive solution for manufacturing that will allow structural CFRP parts to replace metals at a much faster rate in demanding applications in many sectors such as aerospace, automotive and healthcare
Infinity Holding Group to acquire 43.7 per cent stake in Jagsonpal Pharma
By IPP Bureau - February 22, 2022
The transaction as well as the open offer is expected to be completed by June this year.
IFF to acquire contract manufacturer of dietary supplements Health Wright Products
By IPP Bureau - February 22, 2022
The sale is expected to close in the first quarter of 2022
Dow, Sartorius and Südpack collaborate to support global supply of coronavirus vaccines
By IPP Bureau - February 22, 2022
Essential products manufactured by Sartorius, using Sü dpack polymer films made from Dow resins, support safe and effective vaccine production for global vaccine supply
CanSinoBIO's Convidecia approved as heterologous booster in China
By IPP Bureau - February 21, 2022
Heterologous booster vaccination refers to the use of vaccine boosters from different technology platforms from the prime vaccines, which could improve the overall immune response and enhance protection against other variants
Binnopharm acquires two anti-bacterial brands from Dr. Reddy’s
By IPP Bureau - February 21, 2022
Dr. Reddy’s, will focus its resources and capabilities on its key therapy spaces of gastroenterology, pain management, cold and flu, allergy, oncology, neurology, paediatrics and women’s health as the Russia and CIS region continues to be a strong performer for the company
Strides receives USFDA approval for Amantadine Hydrochloride capsules
By IPP Bureau - February 21, 2022
To be marketed by Strides Pharma Inc. in the US market
IIT Delhi develops strategy for development of drug molecules
By IPP Bureau - February 21, 2022
The researchers are of the view that the new drug designing strategy demonstrated by them could also be adopted to treat retroviral infections.
Enhertu Phase III results to redefine how metastatic breast cancer is classifed
By IPP Bureau - February 21, 2022
Enhertu is a HER2-directed antibody drug conjugate (ADC) being jointly developed by AstraZeneca and Daiichi Sankyo.
Snowman Logistics expands its facility in Coimbatore
By IPP Bureau - February 21, 2022
The facility will cater to the storage, handling and transportation of pharma, dairy products seafood among others
